In 2016, Charles A. Reinhart III joined Pacira as Chief Financial Officer, responsible for overseeing all financial and capital market activities at Pacira, including accounting, financial reporting, financial planning and analysis, and investor relations.
Prior to joining Pacira, Mr. Reinhart served as Chief Financial Officer of Covis Pharmaceuticals, Inc. From September 2011 to August 2014, he served as Executive Vice President and Chief Financial Officer of Archimedes Pharma Ltd. Mr. Reinhart also served as Senior Vice President and Chief Financial Officer of PharmAthene, Inc., a biodefense company engaged in the development of next generation medical countermeasures against biological and chemical threats, from 2009 to 2011. He has also held senior financial roles at Millennium Pharmaceuticals, Inc., Cephalon, Inc. and several early-stage life sciences companies. He also served as a director of Osiris Therapeutics, Inc. (Nasdaq: OSIR) from September 2018 until it was acquired in April 2019. Mr. Reinhart has successfully built and managed finance organizations within rapidly growing companies, responsible for accounting and financial reporting, financial planning and analysis, tax, treasury, risk management and procurement. He has worked closely with commercial teams to evaluate sales operations, monitor product pricing and implement contracting strategies. In addition, he has significant experience in investor relations, corporate development and capital raising. He has been integrally involved in equity and debt financing transactions, as well as the evaluation, acquisition and integration of multiple products and companies.
Mr. Reinhart earned his Bachelor of Science degree from Lehigh University and his MBA from the Wharton School of the University of Pennsylvania. He is also a CPA.
What is Charles A. Reinhart, III's net worth?
The estimated net worth of Charles A. Reinhart, III is at least $580,950.20 as of June 6th, 2023. Mr. Reinhart, III owns 34,997 shares of Pacira BioSciences stock worth more than $580,950 as of November 17th. This net worth approximation does not reflect any other assets that Mr. Reinhart, III may own. Learn More about Charles A. Reinhart, III's net worth.
How do I contact Charles A. Reinhart, III?
Has Charles A. Reinhart, III been buying or selling shares of Pacira BioSciences?
Charles A. Reinhart, III has not been actively trading shares of Pacira BioSciences during the last ninety days. Most recently, Charles A. Reinhart III sold 1,236 shares of the business's stock in a transaction on Tuesday, June 6th. The shares were sold at an average price of $38.99, for a transaction totalling $48,191.64. Following the completion of the sale, the chief financial officer now directly owns 34,997 shares of the company's stock, valued at $1,364,533.03. Learn More on Charles A. Reinhart, III's trading history.
Who are Pacira BioSciences' active insiders?
Are insiders buying or selling shares of Pacira BioSciences?
In the last twelve months, Pacira BioSciences insiders bought shares 3 times. They purchased a total of 11,176 shares worth more than $136,240.40. In the last twelve months, insiders at the sold shares 10 times. They sold a total of 113,661 shares worth more than $3,413,175.87. The most recent insider tranaction occured on September, 13th when COO Daryl Gaugler sold 500 shares worth more than $6,430.00. Insiders at Pacira BioSciences own 6.4% of the company.
Learn More about insider trades at Pacira BioSciences. Information on this page was last updated on 9/13/2024.
